Talk to the Institute
Published mark

KIORA PHARMACEUTICALS INC

OTC: KPHMW. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575
SEC CIK
0001372514
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 24, 2026
Newest evidence
Apr 30, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Brian M. Strem, Ph.D.Since Apr 30, 2026
Chair
Not published
Independent
5 / 77 directors published
Published claims
233 distinct sources
Evidence records
50 pinned
Source conflicts
0None open

Built from 3 distinct sources and 5 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

CEO CHANGED

Brian M. Strem, Ph.D. executive of KIORA PHARMACEUTICALS INC, effective 2026-04-30.

EffectiveEffective Apr 30, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
President and Chief Executive OfficerBrian M. Strem, Ph.D.Apr 2026currentSource reportedE3
Chief Financial OfficerMelissa Tosca, CPAApr 2026currentSource reportedE4

Board of directors

Evidence

7 directors published. 5 of 7 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Aron ShapiroNot independent2021None publishedSource reportedE2
Brian M. Strem, Ph.D.Not independent2021None publishedSource reportedE2
Carmine N. StengoneIndependent2023AuditSource reportedE2
David Hollander, MD, MBAIndependent2021Nominating and Governance, chairNominating and Governance · ChairSource reportedE2
Erin ParsonsIndependent2022Compensation, chairCompensation · Chair; Nominating and GovernanceNominating and GovernanceSource reportedE2
Lisa Walters-HoffertIndependent2024Audit, chairAudit · Chair; CompensationCompensationSource reportedE2
Praveen Tyle, Ph.D.Independent2008None publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditLisa Walters-HoffertLisa Walters-Hoffert, Carmine N. StengoneNot described in the published record
Audit · Chair; CompensationNot publishedLisa Walters-HoffertNot described in the published record
CompensationErin ParsonsErin Parsons, Lisa Walters-HoffertNot described in the published record
Compensation · Chair; Nominating and GovernanceNot publishedErin ParsonsNot described in the published record
Nominating and GovernanceDavid Hollander, MD, MBADavid Hollander, MD, MBA, Erin ParsonsNot described in the published record
Nominating and Governance · ChairNot publishedDavid Hollander, MD, MBANot described in the published record
Committee RecordAudit: Chair Lisa Walters-Hoffert; Members Lisa Walters-Hoffert (Chair); Carmine N. Stengone
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_record:14
Committee AppointmentLisa Walters-Hoffert: chair, Audit
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:15
Committee AppointmentCarmine N. Stengone: member, Audit
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:16
Committee RecordCompensation: Chair Erin Parsons; Members Erin Parsons (Chair); Lisa Walters-Hoffert
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_record:17
Committee AppointmentErin Parsons: chair, Compensation
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:18
Committee AppointmentLisa Walters-Hoffert: member, Compensation
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:19
Committee RecordNominating and Governance: Chair David Hollander, MD, MBA; Members David Hollander, MD, MBA (Chair); Erin Parsons
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_record:20
Committee AppointmentDavid Hollander, MD, MBA: chair, Nominating and Governance
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:21
Committee AppointmentErin Parsons: member, Nominating and Governance
Source reportedE5
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:22

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerBrian M. Strem, Ph.D., President and Chief Executive Officer, from Apr 30, 2026
Source reportedE3
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:12
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingKPHMW (OTC)
Source reportedE1
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:security_listing:23
Security ListingKPRX (NASDAQ)
Source reportedE1
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:security_listing:24
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 24, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameKIORA PHARMACEUTICALS INC
Source reportedE1
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:d3fe55ce-f845-4c74-a012-cd513cdf7575:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
5 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 24, 2026. Cited by 5 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30
    sec proxy. Published Apr 30, 2025. Retrieved Apr 28, 2026. Cited by 7 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    KPRX DEF 14A executive officers
    sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    KPRX DEF 14A executive officers
    sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    Audit
    board_seats. board seats. Cited by 9 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 24, 2026
  • Brian M. Strem, Ph.D. executive of KIORA PHARMACEUTICALS INC, effective 2026-04-30.
  • Melissa Tosca, CPA executive of KIORA PHARMACEUTICALS INC, effective 2026-04-30.
  • Lisa Walters-Hoffert seat on KIORA PHARMACEUTICALS INC, effective 2024-01-01.
  • Audit · Chair; Compensation committee of KIORA PHARMACEUTICALS INC, effective 2024-01-01.
  • Lisa Walters-Hoffert member of Audit · Chair; Compensation, effective 2024-01-01.
  • Carmine N. Stengone seat on KIORA PHARMACEUTICALS INC, effective 2023-01-01.
  • Carmine N. Stengone member of Audit, effective 2023-01-01.
  • Erin Parsons seat on KIORA PHARMACEUTICALS INC, effective 2022-01-01.
  • Compensation · Chair; Nominating and Governance committee of KIORA PHARMACEUTICALS INC, effective 2022-01-01.
  • Erin Parsons member of Compensation · Chair; Nominating and Governance, effective 2022-01-01.
  • Aron Shapiro seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01.
  • Brian M. Strem, Ph.D. seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01.
  • David Hollander, MD, MBA seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01.
  • Nominating and Governance · Chair committee of KIORA PHARMACEUTICALS INC, effective 2021-01-01.
  • David Hollander, MD, MBA member of Nominating and Governance · Chair, effective 2021-01-01.
  • Praveen Tyle, Ph.D. seat on KIORA PHARMACEUTICALS INC, effective 2008-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/kiora-pharmaceuticals-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership2
  4. Board7
  5. Committees6
  6. Control and voting0
  7. Authority to act4
  8. Financials2
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people8
  17. Subject and corrections6
  18. Evidence5
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575
  • Cite this recordKIORA PHARMACEUTICALS INC
  • Copy canonical URLregistry.alpha.ac/companies/kiora-pharmaceuticals-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    KIORA PHARMACEUTICALS INCCompany
  • Brian M. Strem, Ph.D.Person
  • Melissa Tosca, CPAPerson
  • Aron ShapiroPerson
  • Carmine N. StengonePerson
  • David Hollander, MD, MBAPerson
  • Erin ParsonsPerson
  • Lisa Walters-HoffertPerson
  • Praveen Tyle, Ph.D.Person
  • Sections
    OverviewKIORA PHARMACEUTICALS INC
  • MonitoringKIORA PHARMACEUTICALS INC
  • LeadershipKIORA PHARMACEUTICALS INC
  • BoardKIORA PHARMACEUTICALS INC
  • CommitteesKIORA PHARMACEUTICALS INC
  • Control and votingKIORA PHARMACEUTICALS INC
  • Authority to actKIORA PHARMACEUTICALS INC
  • FinancialsKIORA PHARMACEUTICALS INC
  • GovernanceKIORA PHARMACEUTICALS INC
  • RiskKIORA PHARMACEUTICALS INC
  • AI oversightKIORA PHARMACEUTICALS INC
  • LegalKIORA PHARMACEUTICALS INC
  • CompensationKIORA PHARMACEUTICALS INC
  • Other published claimsKIORA PHARMACEUTICALS INC
  • Coverage gapsKIORA PHARMACEUTICALS INC
  • Linked peopleKIORA PHARMACEUTICALS INC
  • Subject and correctionsKIORA PHARMACEUTICALS INC
  • EvidenceKIORA PHARMACEUTICALS INC
  • Version historyKIORA PHARMACEUTICALS INC
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.